載入...
Novel fluoronucleoside analog NCC inhibits lamivudine-resistant hepatitis B virus in a hepatocyte model
Antiviral drug resistance is the most important factor contributing to treatment failure using nucleos(t)ide analogs such as lamivudine for chronic infection with hepatitis B virus (HBV). Development of a system supporting efficient replication of clinically resistant HBV strains is imperative, and...
Na minha lista:
Main Authors: | , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Elsevier
2018-11-01
|
叢編: | Brazilian Journal of Infectious Diseases |
在線閱讀: | http://www.sciencedirect.com/science/article/pii/S1413867018304975 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|